§ EQUITY
USDGENB
GENERATE BIOMEDICINES INC
USD
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
68 increased/new, 10 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Flagship Pioneering, LLC | 62.7M | 67.4% | n/a |
| Capital World Investors | 4.0M | 0.0% | n/a |
| BRAIDWELL LP | 3.6M | 1.5% | n/a |
| JPMORGAN CHASE & CO | 2.6M | 0.0% | n/a |
| Fidelity Management | 2.2M | 0.0% | n/a |
| Fidelity Management | 2.0M | 0.0% | n/a |
◇ AC INTELLIGENCE
Top institutional owners for GENB as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER85.9% · 36 holders
QUALITY / COMPOUNDER9.0% · 5 holders
DEALER / BANK4.2% · 9 holders
TACTICAL / MACRO0.5% · 4 holders
PASSIVE / INDEX0.1% · 1 holder
ACTIVIST0.1% · 1 holder
INCOME / DEFENSIVE0.1% · 1 holder
SYSTEMATIC / QUANT0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for GENB in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention GENB yet.